Shomron Ben-Horin
20PUBLICATIONS
43CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (20)
Sort by Publication Date:
|Mar 25, 2026
Pharmacokinetics and efficacy of subcutaneous infliximab 120 mg every 2 weeks: a post hoc comparison with intravenous dosing in a phase 1 study in patients with inflammatory bowel disease.Stefan Schreiber, Byong Duk Ye, Hyunseong Yu
|Nov 28, 2025
One Subcutaneous 2-ml Injection of Mirikizumab is Bioequivalent to Two 1-ml Subcutaneous Injections in Healthy Participants.Yuki Otani, Christopher D Payne, Edward V Loftus
|Nov 13, 2025
Mirikizumab in ulcerative colitis: real-world evidence from an international two-center retrospective cohort study.Asaf Levartovsky, Martin Lukáš, Chaya Mushka Abitbol
|Jun 11, 2025
Intestinal ultrasound measurement of bowel wall thickness can be used as a sole marker for defining anti-TNF maintenance therapy failure in Crohn's disease.Ahmad Albshesh, Shadi Haj, Ido Veisman
|Sep 11, 2024
Differences in disease characteristics and treatment exposures between paediatric and adult-onset inflammatory bowel disease using a registry-based cohort.Maya Granot, Uri Kopylov, Nurit Loberman-Nachum
Pageof 4
Frequent Collaborators
6 joint publications
Uri Kopylov
3 joint publications
Bella Ungar
2 joint publications
Ido Veisman
2 joint publications
Xavier Roblin
2 joint publications
Dong-Hyeon Kim
2 joint publications
Silvio Danese
2 joint publications
Byong Duk Ye
2 joint publications
Ahmad Albshesh
2 joint publications
Geert D'Haens
1 joint publications
S Paul